Box 2. Clinical evaluation of suspected dementia.
| Dementia is identified based on: |
| • Medical history, including from family, friend, or caregiver, focusing on cognition and function |
| • Brief outpatient or bedside cognitive examination |
| • If needed, neuropsychological testing |
| The etiology of dementia is determined based on: |
| • Medical history |
| ➢ Neurologic history |
| ➢ General medical history |
| ➢ Family history |
| • Physical examination |
| ➢ Neurologic signs (e.g., cognitive impairment, focal signs, parkinsonism, other) |
| ➢ Pertinent systemic signs (e.g., for vascular and metabolic diseases) |
| • Neuropsychological testing |
| • Laboratory testing |
| ➢ Thyroid function and vitamin B12 level |
| ➢ Other tests as indicated, such as for metabolic, infectious, autoimmune, and other etiologies* |
| • Structural brain imaging with CT or MRI |
| ➢ AD: generalized or focal cortical atrophy, often asymmetric (hippocampal atrophy) |
| ➢ Vascular contributions to cognitive impairment and dementia: brain infarcts or white matter lesions |
| ➢ Frontotemporal dementia: frontal lobe or anterior temporal lobe atrophy |
| ➢ Other abnormalities such as brain mass (e.g., tumor) and hydrocephalus |
| • Referral to a specialist, for additional neurologic and medical testing, if specific etiologies suspected |
| ➢ Brain tests: electroencephalogram [EEG] |
| ➢ Vascular tests: head and neck magnetic resonance angiogram (MRA) or computed tomography angiogram (CTA) |
| ➢ Cardiac tests: electrocardiogram [ECG], echocardiography, ambulatory cardiac rhythm monitoring |
Depending on the clinical presentation, consider blood tests for a CBC, ESR, chem 7 which includes a glucose level, renal and liver function tests, folic acid, and a RPR.